Related Experiment Videos
Increased REM sleep associated with melatonin deficiency after pinealectomy: a case study.
Laurence Kocher1, Jocelyne Brun, Françoise Borson-Chazot
1Explorations Fonctionnelles et Consultations Neurologiques, Centre Hospitalier Lyon-Sud, Pierre-Bénite cedex, France. laurence.kocher@chu-lyon.fr
Chronobiology International
|August 5, 2006
Summary
This study investigated hypersomnia in a patient post-cancer treatment. Melatonin treatment showed minimal benefit for sleep abnormalities, suggesting hypersomnia is not solely due to melatonin deficiency.
Area of Science:
- Neuroscience
- Endocrinology
- Sleep Medicine
Background:
- Assessing hypersomnia following treatment for a typical germinoma (pinealectomy, chemotherapy, radiotherapy).
- Evaluating the therapeutic potential of exogenous melatonin in a patient with absent endogenous melatonin secretion.
Observation:
- A young patient developed progressive hypersomnia after cancer treatment.
- Sleep studies revealed abnormal sleep latency and REM sleep onsets.
- Hormonal profiles (melatonin, cortisol, growth hormone, prolactin) and temperature rhythms were monitored.
Findings:
- Melatonin replacement normalized plasma melatonin levels but yielded only minor improvements in sleep abnormalities, including REM sleep.
- Melatonin treatment did not affect cortisol or growth hormone secretion but normalized prolactin secretion.
- A 24-hour temperature rhythm persisted but showed dampened amplitude and decreased mean level during melatonin treatment.
Implications:
- Hypersomnia in this case is likely multifactorial, not solely attributable to melatonin deficiency.
- Exogenous melatonin offers limited benefit for post-treatment hypersomnia, with modafinil potentially still required.
- Further research is needed to understand the complex interplay of treatments and sleep regulation.